BackJiangsu Hengrui Pharmaceuticals ,Ltd Overview

Jiangsu Hengrui Pharmaceuticals ,Ltd Receivables

Track Jiangsu Hengrui Pharmaceuticals ,Ltd's receivables ($7.6B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$7.56B
↑ 20.67% YoYΔ $1.29B vs prior year quarter

Peer trimmed avg / median

Loading

Jiangsu Hengrui Pharmaceuticals ,Ltd Receivables History

Loading

Jiangsu Hengrui Pharmaceuticals ,Ltd vs. peers: Receivables Comparison

Loading

Jiangsu Hengrui Pharmaceuticals ,Ltd Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Jiangsu Hengrui Pharmaceuticals ,Ltd (1276.HK) FAQ

Jiangsu Hengrui Pharmaceuticals ,Ltd (1276.HK) currently reports a receivables of $7.6B as of September 2026. That compares with $6.3B in the prior-year period — up 20.7% year over year. Use the charts on this page to explore Jiangsu Hengrui Pharmaceuticals ,Ltd's receivables history and peer comparisons.

Jiangsu Hengrui Pharmaceuticals ,Ltd's receivables increased from $6.3B to $7.6B — a 20.7% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Jiangsu Hengrui Pharmaceuticals ,Ltd reported $7.6B in receivables as of September 2026. That compares with $6.3B in the prior-year period — up 20.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $7.6B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Jiangsu Hengrui Pharmaceuticals ,Ltd, and consider following 1276.HK for alerts when major investors trade the stock.